Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PRENTICE, A. G")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 19 of 19

  • Page / 1
Export

Selection :

  • and

The plasminogen activator system in women with polycystic ovary syndromeATIOMO, W. U; BATES, S. A; CONDON, J. E et al.Fertility and sterility. 1998, Vol 69, Num 2, pp 236-241, issn 0015-0282Conference Paper

Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemiaBRADFORD, C. R; PRENTICE, A. G; WARNOCK, D. W et al.Journal of antimicrobial chemotherapy (Print). 1991, Vol 28, Num 4, pp 555-560, issn 0305-7453Article

Treatment of acute myeloid leukaemia with early intensive induction therapyJOHNSON, S. A; PRENTICE, A. G; PHILLIPS, M. J et al.Acta oncologica (Stockholm). 1988, Vol 27, Num 5, pp 527-529, issn 0284-186XConference Paper

Avascular necrosis of bone following intensified steroid therapy for acute lymphoblastic leukaemia and high-grade malignant lymphomaCHAN-LAM, D; PRENTICE, A. G; COPPLESTONE, J. A et al.British journal of haematology. 1994, Vol 86, Num 1, pp 227-230, issn 0007-1048Article

Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myelomaCHAPEL, H. M; LEE, M; HARGREAVES, R et al.Lancet (British edition). 1994, Vol 343, Num 8905, pp 1059-1063, issn 0140-6736Article

Acquired factor XI inhibitor in chronic lymphocytic leukaemiaGOODRICK, M. J; PRENTICE, A. G; COPPLESTONE, J. A et al.Journal of clinical pathology. 1992, Vol 45, Num 4, pp 352-353, issn 0021-9746Article

Prophylaxis of fungal infections with itraconazole during remission-induction therapyPRENTICE, A. G; BRADFORD, G. R.Mycoses. 1989, Vol 32, pp 96-102, issn 0933-7407, 7 p., suppl. 1Conference Paper

p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategiesWICKREMASINGHE, R. G; PRENTICE, A. G; STEELE, A. J et al.Leukemia. 2011, Vol 25, Num 9, pp 1400-1407, issn 0887-6924, 8 p.Article

In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybridsGODDARD, R. V; PRENTICE, A. G; COPPLESTONE, J. A et al.Clinical and experimental immunology (Print). 2003, Vol 131, Num 1, pp 82-89, issn 0009-9104, 8 p.Article

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignanciesMORGENSTERN, G. R; PRENTICE, A. G; PRENTICE, H. G et al.British journal of haematology. 1999, Vol 105, Num 4, pp 901-911, issn 0007-1048Article

Photosensitivity and lymphomaBUSUTTIL, D. P; DAVIES, M. G; COPPLESTONE, J. A et al.Postgraduate medical journal. 1997, Vol 73, Num 861, pp 435-437, issn 0032-5473Article

New glucose-6-phosphate dehydrogenase mutations associated with chronic anemiaMASON, P. J; SONATI, M. F; ALTAY, C et al.Blood. 1995, Vol 85, Num 5, pp 1377-1380, issn 0006-4971Article

Haematological toxicity compromises MOPP/ABVD chemotherapy on Hodgkin's diseaseGOODRICK, M. J; DANIEL, F; PRENTICE, A. G et al.Clinical oncology. 1991, Vol 3, Num 3, pp 151-154Article

Nomograms for the administration of unfractionated heparinGRUBB, H; LOVETT, J; KINGMAN, H. M et al.Thrombosis and haemostasis. 2001, Vol 85, Num 3, issn 0340-6245, p. 565Article

Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS)ATIOMO, W. U; FOX, R; CONDON, J. E et al.Clinical endocrinology (Oxford. Print). 2000, Vol 52, Num 4, pp 487-492, issn 0300-0664Article

Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cellsMAINOU-FOWLER, T; COPPLESTONE, J. A; PRENTICE, A. G et al.Journal of clinical pathology. 1995, Vol 48, Num 5, pp 482-487, issn 0021-9746Article

Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemiaPRENTICE, A. G; WARNOCK, D. W; JOHNSON, S. A. N et al.Journal of antimicrobial chemotherapy (Print). 1995, Vol 36, Num 4, pp 657-663, issn 0305-7453Article

Inaccurate haemoglobin estimation in Waldenström's macroglobulinaemia : unusual reaction with monomeric IgM paraproteinGOODRICK, M. J; BOON, R. J; BISHOP, R. J. D et al.Journal of clinical pathology. 1993, Vol 46, Num 12, pp 1138-1139, issn 0021-9746Article

Restoration of active haemopoiesis in a patient with myelofibrosis and subsequent termination in acute myeloblastic leukaemia: case report and review of the literaturePAMPHILON, D. H; CREAMER, P; KEELING, D. H et al.European journal of haematology. 1987, Vol 38, Num 3, pp 279-283, issn 0902-4441Article

  • Page / 1